COGT · Cogent Biosciences, Inc. · Proposed Sales
$30.38
-0.49 (-1.59%)
At close · Oct 6
Return incl. dividend (before tax)
Market Cap
$5.62B
Shares
173.52M
Volume · Oct 6
2.38M
Avg daily vol (3M)
1.97M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-08-27 | ARLENE MORRIS | Director | 45,510 | 2026-08-27 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-31 | Fairmount Healthcare Fund II L.P. | Director | 7,000,000 | 2026-03-31 | Goldman Sachs & Co. LLC |
| 2026-01-22 | Fairmount Healthcare Fund II L.P. | Director | 3,500,000 | 2026-01-22 | Jefferies LLC |
| 2025-12-29 | JOHN GREEN | Officer | 77,000 | 2025-12-26 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-29 | JOHN ROBINSON | Officer | 90,000 | 2025-12-26 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-29 | EVAN D KEARNS | Officer | 65,000 | 2025-12-26 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-29 | JESSICA SACHS | Officer | 82,642 | 2025-12-26 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–7 of 7 filings